Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Apr 20, 2007 11:46am
438 Views
Post# 12646439

RE: Next Move UP – Ready, Set, winer!

RE: Next Move UP – Ready, Set, winer! What NR are you refering to winer? The $48 million question? You really need to buy that new sound card winer.........Dr. Cruz has been doing a lot of presentations of late and giving good guidance. They have all been webcast. I took the time to summarize, from my transcriptions, Dr. Cruz's ramblings from the World Markets Bio webcast to post on this board......... ......another presentation from Dr. Cruz next week as well. Interest generated from this financially focused partner finding conference could put pressure on those parties Transition is currently in talks with for GLP1-INT to up the ante and speed up the process. https://www.biofinance.ca/TransitionTherapeuticsInc I don't think this one is webcast. Could be. AZD-103 is nearing completion. The FDA approved Phaselb study's are all done and the data is being compiled except for a few Phasel's looking at levels in CSF and effects of diet. That all should be completed middle May to end of May. Could be earlier. Dr. Cruz stated and I quote....... "Our upcoming Milestones for this year includes completing AZD-103 Phase1's and I do believe they will be completed by end of April sometime,(pause), by end of May for sure." Phasel for GLP1-INT is finishing up here right away as well but they are rather quiet about it...........Patent Security I would think. A few quips from Dr. Cruz in NYC if anyones interested...... https://www.stockhouse.ca/bullboards/viewmessage.asp?no=14668293&tableid=
Bullboard Posts